Strode Comments on Risks of Acquiring Cash-Strapped Hospitals
July 6, 2018
Healthcare Finance
Partner Roger Strode was quoted in a Healthcare Finance article, “Why acquiring a cash-strapped hospital brings new levels of risk,” about the financial, branding, and cultural considerations that should be weighed when deciding to acquire or merge with another hospital.
Strode said such deals require a tremendous amount of due diligence, from hiring lawyers and outside accountants to understanding the material contracts to devising a five-to 10-year financial plan.
“There’s a certain amount of mission-driven thinking that goes into this,” he said. “If you’ve seen one of these deals, you’ve seen one of these deals. Healthcare is local, markets are different, so every deal is a little bit different. Some feel that if they don’t grab it now, their competitors will grab it, so they’ll fix the problems after they get it. Sometimes there’s a concern they’ll go to bankruptcy, and then it’s really difficult to acquire them.”
Strode said such deals require a tremendous amount of due diligence, from hiring lawyers and outside accountants to understanding the material contracts to devising a five-to 10-year financial plan.
“There’s a certain amount of mission-driven thinking that goes into this,” he said. “If you’ve seen one of these deals, you’ve seen one of these deals. Healthcare is local, markets are different, so every deal is a little bit different. Some feel that if they don’t grab it now, their competitors will grab it, so they’ll fix the problems after they get it. Sometimes there’s a concern they’ll go to bankruptcy, and then it’s really difficult to acquire them.”
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.